Eisai
4523.T
#2302
Rank
NZ$14.24 B
Marketcap
NZ$50.50
Share price
-1.71%
Change (1 day)
5.89%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.51. an increase over its 2024 EPS that were of NZ$1.70.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.9011.85%
2024NZ$1.70-32.63%
2023NZ$2.525.52%
2022NZ$2.39-74.01%
2021NZ$9.21-66.58%
2020NZ$27.5498.24%
2019NZ$13.8917.01%
2018NZ$11.8737.78%
2017NZ$8.62-27.62%
2016NZ$11.9135.33%
2015NZ$8.80-2.82%
2014NZ$9.05-27.66%
2013NZ$12.52-27.49%
2012NZ$17.26-12.67%
2011NZ$19.7788.08%
2010NZ$10.51-11.06%
2009NZ$11.82-390.15%
2008NZ-$4.07-127.78%
2007NZ$14.6611.78%
2006NZ$13.124.38%
2005NZ$12.577.4%
2004NZ$11.7043.03%
2003NZ$8.1825.09%
2002NZ$6.5452.67%
2001NZ$4.2869.76%
2000NZ$2.52